The South Korea Atherosclerosis Drugs Market Size is Anticipated to reach a significant share By 2033, Growing at a CAGR of 3.19% from 2023 to 2033 South Korea atherosclerosis drugs market includes statins, PCSK9 inhibitors, and other drugs designed to manage cholesterol levels, reduce inflammation, and improve heart health.